拨康视云-B(02592)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02592 拨康视云-B

未开盘 12-05 16:09:08

8.000

-1.510

-15.88%

最高9.580	最低7.350	成交量559.50万
今开9.500	昨收9.510	日振幅23.45%
总市值67.60亿	流通市值67.60亿	总股本8.45亿
成交额4,707万	换手率0.66%	流通股本8.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"拨康视云-B","latestPrice":8,"timestamp":1764922148004,"preClose":9.51,"halted":0,"volume":5595000,"delay":0,"floatShares":844999999,"shares":844999999,"eps":-1.6233058533205664,"marketStatus":"未开盘","change":-1.51,"latestTime":"12-05 16:09:08","open":9.5,"high":9.58,"low":7.35,"amount":47072990,"amplitude":0.23449,"askPrice":8,"askSize":15500,"bidPrice":7.92,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.3112247678211386,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":9.51,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.6699434767509567,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02592","defaultTab":"news","newsList":[{"id":"2588385998","title":"每日卖空追踪 | 拨康视云-B 12月04日卖空量成交1.7万股，卖空比例为0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588385998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588385998?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837032,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间12月04日，涨6.97%，卖空量成交1.7万股，较上一交易日减少63.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163506952a7c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163506952a7c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2588838597","title":"拨康视云-B12月04日获主力加仓79.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588838597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588838597?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836145,"startTime":"0","endTime":"0","summary":"12月04日, 拨康视云-B股价涨6.97%，报收9.51元，成交金额1840.1万元，换手率0.24%，振幅8.89%，量比0.47。拨康视云-B今日主力资金净流入79.7万元，上一交易日主力净流入149.3万元。该股近5个交易日上涨30.17%，主力资金累计净流入1933.4万元；近20日主力资金累计净流入4574.2万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161946952a7335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161946952a7335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2588088954","title":"港股异动 | 拨康视云-B(02592)盘中涨超4% 近一周累计涨幅逾八成 公司将加速CBT-009全球商业化潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2588088954","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588088954?lang=zh_cn&edition=full","pubTime":"2025-12-02 10:20","pubTimestamp":1764642042,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，拨康视云-B盘中涨超4%，近一周交易日累计涨幅逾八成。消息面上，近日，拨康视云-B发布公告，公司于美国特拉华州注册成立的全资附属公司ADS Therapeutics LLC已成功在日本及欧洲成功申请专利，该等专利涉及集团核心产品之一CBT-009。公司认为，该等专利申请的成功是CBT-009研发进程中的重要里程碑，将提升CBT-009的全球覆盖范围，并促进商业化进程。有关合作及许可安排预期将提升并加速CBT-009的全球商业化潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","CBT","BK4090","02592"],"gpt_icon":0},{"id":"2588725450","title":"每日卖空追踪 | 拨康视云-B 12月01日卖空量成交4.85万股，卖空比例为1.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588725450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588725450?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577831,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间12月01日，涨2.54%，卖空量成交4.85万股，较上一交易日减少37.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163440a4c55194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163440a4c55194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2588725492","title":"拨康视云-B12月01日获主力加仓243.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588725492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588725492?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576945,"startTime":"0","endTime":"0","summary":"12月01日, 拨康视云-B股价涨2.54%，报收8.49元，成交金额2285.6万元，换手率0.33%，振幅8.09%，量比0.46。拨康视云-B今日主力资金净流入243.9万元，连续6日净流入，上一交易日主力净流入1349.5万元。该股近5个交易日上涨63.27%，主力资金累计净流入4157.7万元；近20日主力资金累计净流入4185.4万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116191795243f99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116191795243f99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2586270978","title":"维升药业-B盘中异动 大幅拉升5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586270978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586270978?lang=zh_cn&edition=full","pubTime":"2025-11-28 10:28","pubTimestamp":1764296913,"startTime":"0","endTime":"0","summary":"2025年11月28日早盘10时28分，维升药业-B股票出现异动，股价快速上涨5.82%。截至发稿，该股报32.020港元/股，成交量5400股，换手率0.00%，振幅6.81%。维升药业-B股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，华康生物医学、拨康视云-B、维升药业-B涨幅较大，振幅较大的相关个股有拨康视云-B、派格生物医药-B、科笛-B，振幅分别为14.74%、11.43%、7.75%。维升药业-B公司简介：维升药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128102833a4bf4a54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128102833a4bf4a54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161","02561"],"gpt_icon":0},{"id":"2586227105","title":"港股异动 | 拨康视云-B(02592)再涨超10% 核心产品CBT-009获得日本及欧洲专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2586227105","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586227105?lang=zh_cn&edition=full","pubTime":"2025-11-28 09:44","pubTimestamp":1764294298,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，拨康视云-B再涨超10%，本周累计涨幅接近70%。截至发稿，涨8.82%，报7.9港元，成交额621.89万港元。消息面上，拨康视云发布公告，美国全资附属ADS USA成功获日本专利局及欧洲专利局授出专利，涉及集团核心产品之一CBT-009。CBT-009是一种新型阿托品眼用制剂，用于治疗5至19岁儿童及青少年的青少年近视。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4090","02592","CBT","BK1161"],"gpt_icon":0},{"id":"2586226049","title":"即将进入解禁“一个月倒计时”，拨康视云-B却上演“量价”齐升？","url":"https://stock-news.laohu8.com/highlight/detail?id=2586226049","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586226049?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:09","pubTimestamp":1764245387,"startTime":"0","endTime":"0","summary":"凭借此前平淡表现与近日一波大涨行情形成的反差，拨康视云吸引了不少关注，而此时又恰逢该公司即将进入基石解禁的“一个月倒计时”，在禁售期如此暴力拉升股价，也让部分投资者担心此股会不会成为下一个“熙康云医院”。即将进入解禁“一个月倒计时”正如上文提到，自上市至今，拨康视云股价便一直处在波动下行通道中。但从随后的暗盘表现来看，拨康视云仅收涨4.95%，上市首日更是大幅破发，这显然与市场认知中的“套路回拨”不同。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511272014179782bcb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511272014179782bcb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2586242898","title":"拨康视云-B(02592)于日本及欧洲成功申请专利 将提升并加速CBT-009的全球商业化潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2586242898","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586242898?lang=zh_cn&edition=full","pubTime":"2025-11-27 19:27","pubTimestamp":1764242834,"startTime":"0","endTime":"0","summary":"CBT-009作为集团的核心产品，是一种新型阿托品眼用制剂，用于治疗5至19岁儿童及青少年的青少年近视。集团亦已于2025年2月在中国开展幼年动物毒性研究，并正积极筹备CBT-009第3期临床试验的启动事宜。公司认为，该等专利申请的成功是CBT-009研发进程中的重要里程碑，将提升CBT-009的全球覆盖范围，并促进商业化进程。有关合作及许可安排预期将提升并加速CBT-009的全球商业化潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CBT","BK1161","02592","BK4090"],"gpt_icon":0},{"id":"2586229886","title":"拨康视云-B：李朝昌获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2586229886","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586229886?lang=zh_cn&edition=full","pubTime":"2025-11-27 18:25","pubTimestamp":1764239100,"startTime":"0","endTime":"0","summary":"拨康视云-B发布公告，赖显荣先生已提交辞呈，辞任独立非执行董事、公司提名委员会主席、公司审核委员会成员及公司薪酬委员会成员，自2025年12月1日起生效;李朝昌先生将获委任为独立非执行董事、审核委员会成员及提名委员会成员，自2025年12月1日起生效;及董事会主席、执行董事兼公司首席执行官NI Jinsong博士将获委任为提名委员会主席，自2025年12月1日起生效。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127182736951d8952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127182736951d8952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2586246731","title":"拨康视云-B(02592)：国卫已获委任为核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246731","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586246731?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:51","pubTimestamp":1764237103,"startTime":"0","endTime":"0","summary":"智通财经APP讯，拨康视云-B(02592)发布公告，罗兵咸永道会计师事务所(罗兵咸永道)已辞任本公司核数师，自 2025年11月27日起生效。根据审核委员会的推荐，国卫会计师事务所有限公司(国卫)已获委任为本公司核数师，自2025年11月27日起生效，以填补罗兵咸永道辞任后的临时空缺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2586218827","title":"维升药业-B盘中异动 大幅上涨5.88%报30.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586218827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586218827?lang=zh_cn&edition=full","pubTime":"2025-11-27 09:34","pubTimestamp":1764207293,"startTime":"0","endTime":"0","summary":"2025年11月27日早盘09时34分，维升药业-B股票出现异动，股价快速上涨5.88%。截至发稿，该股报30.960港元/股，成交量1000股，换手率0.00%，振幅2.94%。资金方面，该股资金流入1.224万港元，流出9116港元。维升药业-B股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，维升药业-B、博安生物、派格生物医药-B涨幅较大，振幅较大的相关个股有派格生物医药-B、药明巨诺-B、拨康视云-B，振幅分别为8.33%、7.17%、6.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093453a71404d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093453a71404d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561","02592"],"gpt_icon":0},{"id":"2586521627","title":"拨康视云-B盘中异动 早盘股价大跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586521627","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586521627?lang=zh_cn&edition=full","pubTime":"2025-11-27 09:31","pubTimestamp":1764207109,"startTime":"0","endTime":"0","summary":"2025年11月27日早盘09时31分，拨康视云-B股票出现异动，股价快速下挫5.66%。截至发稿，该股报6.670港元/股，成交量13.75万股，换手率0.02%，振幅6.65%。拨康视云-B股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，博安生物、派格生物医药-B、维升药业-B涨幅较大，振幅较大的相关个股有派格生物医药-B、MIRXES-B、加科思-B，振幅分别为8.33%、6.35%、6.00%。拨康视云-B公司简介：Cloudbreak Pharma Inc是一家临床阶段的眼科生物技术公司,从事开发各种治疗方法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093149a4bcddcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093149a4bcddcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2586216789","title":"每日卖空追踪 | 拨康视云-B 11月26日卖空量成交6.05万股，卖空比例为0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586216789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586216789?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:30","pubTimestamp":1764145828,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间11月26日，涨22.32%，卖空量成交6.05万股，较上一交易日增加2.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511261634329780533d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511261634329780533d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2585246319","title":"每日卖空追踪 | 拨康视云-B 11月24日卖空量成交1.1万股，卖空比例为0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585246319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585246319?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:30","pubTimestamp":1763973031,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间11月24日，涨9.47%，卖空量成交1.1万股，较上一交易日减少65.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163434977c1f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163434977c1f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2585463172","title":"拨康视云-B盘中异动 早盘股价大涨5.05%报4.990港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585463172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585463172?lang=zh_cn&edition=full","pubTime":"2025-11-24 10:57","pubTimestamp":1763953030,"startTime":"0","endTime":"0","summary":"2025年11月24日早盘10时57分，拨康视云-B股票出现波动，股价大幅上涨5.05%。截至发稿，该股报4.990港元/股，成交量39.6万股，换手率0.05%，振幅4.42%。资金方面，该股资金流入143.178万港元，流出40.491万港元。拨康视云-B股票所在的生物技术行业中，整体涨幅为2.56%。该公司拥有两款核心产品 CBT-001和CBT-009,均为自主研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511241057109516956f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511241057109516956f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2584153533","title":"每日卖空追踪 | 拨康视云-B 11月20日卖空量成交7500股，卖空比例为1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584153533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584153533?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627431,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间11月20日，跌4.08%，卖空量成交7500股，较上一交易日减少69.39%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016363195103bea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016363195103bea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2584153304","title":"拨康视云-B11月20日主力净流出65.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2584153304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584153304?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:15","pubTimestamp":1763626538,"startTime":"0","endTime":"0","summary":"11月20日, 拨康视云-B股价跌4.08%，报收4.70元，成交金额297.2万元，换手率0.07%，振幅6.94%，量比1.32。拨康视云-B今日主力资金净流出65.1万元，上一交易日主力净流入18.6万元。该股近5个交易日上涨2.87%，主力资金累计净流出25.1万元；近20日主力资金累计净流出44.4万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120161855a4aec116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120161855a4aec116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2584908548","title":"每日卖空追踪 | 拨康视云-B 11月19日卖空量成交1.4万股，卖空比例为1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584908548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584908548?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:30","pubTimestamp":1763541029,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间11月19日，涨6.29%，卖空量成交1.4万股，较上一交易日减少83.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163453a703dd33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163453a703dd33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2584981907","title":"拨康视云-B盘中异动 早盘急速拉升5.31%报4.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584981907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584981907?lang=zh_cn&edition=full","pubTime":"2025-11-18 11:29","pubTimestamp":1763436576,"startTime":"0","endTime":"0","summary":"2025年11月18日早盘11时29分，拨康视云-B股票出现异动，股价急速拉升5.31%。截至发稿，该股报4.560港元/股，成交量31.75万股，换手率0.04%，振幅6.70%。资金方面，该股资金流入123.347万港元，流出12.1405万港元。拨康视云-B股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，中生北控生物科技、药捷安康-B、拨康视云-B涨幅较大，振幅较大的相关个股有中生北控生物科技、思路迪医药股份、旺山旺水-B，振幅分别为29.41%、18.44%、9.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118112936950b43c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118112936950b43c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0}],"profile":{"websiteUrl":"http://cloudbreakpharma.com","stockEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":0.8307},{"period":"3month","weight":0.6032},{"period":"6month","weight":-0.2079},{"period":"ytd","weight":-0.2079}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Cloudbreak Pharma Inc是一家临床阶段的眼科生物技术公司，从事开发各种治疗方法。该公司专注于眼科疗法的内部发现、开发和商业化。该公司拥有两款核心产品 CBT-001和CBT-009，均为自主研发。该公司的核心产品CBT-001用于治疗翼状胬肉（一种良性增生性眼表疾病），已在美国和中国启动III期多区域临床试验（MRCT）。该公司的核心产品CBT-009用于治疗青少年近视（5至19岁儿童和青少年的近视），已完成I/II期临床试验。该公司的其他候选药物处于相对早期的开发阶段，包括另外两种临床阶段候选药物，即CBT-006和CBT-004，以及四种临床前阶段候选药物，即CBT-007、CBT-199、CBT-145和CBT-011。","exchange":"SEHK","name":"拨康视云-B","nameEN":"CLOUDBREAK-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"拨康视云-B(02592)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供拨康视云-B(02592)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"拨康视云-B,02592,拨康视云-B股票,拨康视云-B股票老虎,拨康视云-B股票老虎国际,拨康视云-B行情,拨康视云-B股票行情,拨康视云-B股价,拨康视云-B股市,拨康视云-B股票价格,拨康视云-B股票交易,拨康视云-B股票购买,拨康视云-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"拨康视云-B(02592)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供拨康视云-B(02592)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}